{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:58:08Z","timestamp":1778227088228,"version":"3.51.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T00:00:00Z","timestamp":1501718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1038\/aps.2017.54","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T10:04:47Z","timestamp":1501754687000},"page":"1554-1565","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Acute liver failure enhances oral plasma exposure of zidovudine in rats by downregulation of hepatic UGT2B7 and intestinal P-gp"],"prefix":"10.1038","volume":"38","author":[{"given":"Fan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-xing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin-bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-ge","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,3]]},"reference":[{"key":"BFaps201754_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3748\/wjg.v22.i1.72","volume":"22","author":"CG Dietrich","year":"2016","unstructured":"Dietrich CG, Gotze O, Geier A . Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance. World J Gastroenterol 2016; 22: 72\u201388.","journal-title":"World J Gastroenterol"},{"key":"BFaps201754_CR2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/0006-2952(94)00515-N","volume":"49","author":"J George","year":"1995","unstructured":"George J, Liddle C, Murray M, Byth K, Farrell GC . Pretranslational regulation of cytochrome-p450 genes is responsible for disease-specific changes of individual p450 enzymes among patients with cirrhosis. Biochem Pharmacol 1995; 49: 873\u201381.","journal-title":"Biochem Pharmacol"},{"key":"BFaps201754_CR3","first-page":"120","volume":"21","author":"J George","year":"1995","unstructured":"George J, Murray M, Byth K, Farrell GC . Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology 1995; 21: 120\u20138.","journal-title":"Hepatology"},{"key":"BFaps201754_CR4","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1124\/dmd.113.050930","volume":"41","author":"EB Yalcin","year":"2013","unstructured":"Yalcin EB, More V, Neira KL, Lu ZQ, Cherrington NJ, Slitt AL, et al. Downregulation of sulfotransferase expression and activity in diseased human livers. Drug Metab Dispos 2013; 41: 1642\u201350.","journal-title":"Drug Metab Dispos"},{"key":"BFaps201754_CR5","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1124\/dmd.112.049676","volume":"41","author":"VR More","year":"2013","unstructured":"More VR, Cheng QQ, Donepudi AC, Buckley DB, Lu ZJ, Cherrington NJ, et al. Alcohol cirrhosis alters nuclear receptor and drug transporter expression in human liver. Drug Metab Dispos 2013; 41: 1148\u201355.","journal-title":"Drug Metab Dispos"},{"key":"BFaps201754_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1086\/426021","volume":"40","author":"DL Wyles","year":"2005","unstructured":"Wyles DL, Gerber JG . Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction. Clin Infect Dis 2005; 40: 174\u201381.","journal-title":"Clin Infect Dis"},{"key":"BFaps201754_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2009.10.002","volume":"85","author":"S Broder","year":"2010","unstructured":"Broder S . The development of antiretroviral therapy and its impact on the HIV-1\/AIDS pandemic. Antivir Res 2010; 85: 1\u201318.","journal-title":"Antivir Res"},{"key":"BFaps201754_CR8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jama.2014.8722","volume":"312","author":"HF Gunthard","year":"2014","unstructured":"Gunthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, et al. Antiretroviral Treatment of Adult HIV Infection 2014 Recommendations of the International Antiviral Society-USA Panel. JAMA 2014; 312: 410\u201325.","journal-title":"JAMA"},{"key":"BFaps201754_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1468-1293.2007.00533.x","volume":"9","author":"N Clumeck","year":"2008","unstructured":"Clumeck N, Pozniak A, Raffi F, Committee EE . European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults. Hiv Med 2008; 9: 65\u201371.","journal-title":"Hiv Med"},{"key":"BFaps201754_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1473-3099(15)00319-9","volume":"16","author":"V Mulenga","year":"2016","unstructured":"Mulenga V, Musiime V, Kekitiinwa A, Cook AD, Abongomera G, Kenny J, et al. Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial. Lancet Infect Dis 2016; 16: 169\u201379.","journal-title":"Lancet Infect Dis"},{"key":"BFaps201754_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.apsb.2015.10.002","volume":"6","author":"L Mu","year":"2016","unstructured":"Mu L, Zhou R, Tang F, Liu X, Li S, Xie F, et al. Intracellular pharmacokinetic study of zidovudine and its phosphorylated metabolites. Acta Pharm Sin B 2016; 6: 158\u201362.","journal-title":"Acta Pharm Sin B"},{"key":"BFaps201754_CR12","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.clinthera.2008.05.003","volume":"30","author":"CHDR Serra","year":"2008","unstructured":"Serra CHDR, Koono EEM, Kano EK, Schramm SG, Armando YP, Porta V . Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: An open-label, randomized, single-dose, two-way crossover study. Clin Ther 2008; 30: 902\u20138.","journal-title":"Clin Ther"},{"key":"BFaps201754_CR13","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/0306-3623(95)00047-X","volume":"26","author":"GJ Veal","year":"1995","unstructured":"Veal GJ, Back DJ . Metabolism of zidovudine. Gen Pharmacol 1995; 26: 1469\u201375.","journal-title":"Gen Pharmacol"},{"key":"BFaps201754_CR14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0090-9556(24)15092-1","volume":"28","author":"O Barbier","year":"2000","unstructured":"Barbier O, Turgeon D, Girard C, Green MD, Tephly TR, Hum DW, et al. 3'-azido-3'-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7). Drug Metab Dispos 2000; 28: 497\u2013502.","journal-title":"Drug Metab Dispos"},{"key":"BFaps201754_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0076-6879(05)00007-8","volume":"400","author":"MH Court","year":"2005","unstructured":"Court MH . Enzyme-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases. Methods Enzymol 2005; 400: 104\u201316.","journal-title":"Methods Enzymol"},{"key":"BFaps201754_CR16","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/00126334-199109000-00007","volume":"4","author":"S Child","year":"1991","unstructured":"Child S, Montaner J, Tsoukas C, Fanning M, Le T, Wall RA, et al. Canadian multicenter azidothymidine trial: AZT pharmacokinetics. J Acquir Immune Defic Syndr 1991; 4: 865\u201370.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"BFaps201754_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/clpt.1990.101","volume":"47","author":"AM Taburet","year":"1990","unstructured":"Taburet AM, Naveau S, Zorza G, Colin JN, Delfraissy JF, Chaput JC, et al. Pharmacokinetics of zidovudine in patients with liver cirrhosis. Clin Pharmacol Ther 1990; 47: 731\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"BFaps201754_CR18","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1128\/AAC.39.12.2732","volume":"39","author":"KH Moore","year":"1995","unstructured":"Moore KH, Raasch RH, Brouwer KL, Opheim K, Cheeseman SH, Eyster E, et al. Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062). Antimicrob Agents Chemother 1995; 39: 2732\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"BFaps201754_CR19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0022-3565(24)38249-7","volume":"289","author":"V Furlan","year":"1999","unstructured":"Furlan V, Demirdjian S, Bourdon O, Magdalou J, Taburet AM . Glucuronidation of drugs by hepatic microsomes derived from healthy and cirrhotic human livers. J Pharmacol Exp Ther 1999; 289: 1169\u201375.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps201754_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.antiviral.2015.09.013","volume":"123","author":"A Dalpiaz","year":"2015","unstructured":"Dalpiaz A, Fogagnolo M, Ferraro L, Capuzzo A, Pavan B, Rassu G, et al. Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries. Antiviral Res 2015; 123: 146\u201357.","journal-title":"Antiviral Res"},{"key":"BFaps201754_CR21","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1124\/dmd.106.014274","volume":"35","author":"G Pan","year":"2007","unstructured":"Pan G, Giri N, Elmquist WF . Abcg2\/Bcrp1 mediates the polarized transport of antiretroviral nucleosides abacavir and zidovudine. Drug Metab Dispos 2007; 35: 1165\u201373.","journal-title":"Drug Metab Dispos"},{"key":"BFaps201754_CR22","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1002\/jps.21744","volume":"98","author":"J De Souza","year":"2009","unstructured":"De Souza J, Benet LZ, Huang Y, Storpirtis S . Comparison of bidirectional lamivudine and zidovudine transport using MDCK, MDCK-MDR1, and caco-2 cell monolayers. J Pharm Sci 2009; 98: 4413\u20139.","journal-title":"J Pharm Sci"},{"key":"BFaps201754_CR23","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/jnc.13666","volume":"138","author":"Y Li","year":"2016","unstructured":"Li Y, Zhang J, Xu P, Sun BB, Zhong ZY, Liu C, et al. Acute liver failure impairs function and expression of breast cancer-resistant protein (BCRP) at rat blood-brain barrier partly via ammonia-ROS-ERK1\/2 activation. J Neurochem 2016; 138: 282\u201394.","journal-title":"J Neurochem"},{"key":"BFaps201754_CR24","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1478-3231.2012.02862.x","volume":"33","author":"S Jin","year":"2013","unstructured":"Jin S, Wang XT, Liu L, Yao D, Liu C, Zhang M, et al. P-glycoprotein and multidrug resistance-associated protein 2 are oppositely altered in brain of rats with thioacetamide-induced acute liver failure. Liver Int 2013; 33: 274\u201382.","journal-title":"Liver Int"},{"key":"BFaps201754_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jns.2006.10.014","volume":"252","author":"KV Sathyasaikumar","year":"2007","unstructured":"Sathyasaikumar KV, Swapna I, Reddy PVB, Murthy CRK, Roy KR, Gupta AD, et al. Co-administration of C-phycocyanin ameliorates thioacetamide-induced hepatic encephalopathy in Wistar rats. J Neurol Sci 2007; 252: 67\u201375.","journal-title":"J Neurol Sci"},{"key":"BFaps201754_CR26","first-page":"164","volume":"14","author":"M Farjam","year":"2012","unstructured":"Farjam M, Dehdab P, Abbassnia F, Mehrabani D, Tanideh N, Pakbaz S, et al. Thioacetamide-induced acute hepatic encephalopathy in rat: behavioral, biochemical and histological changes. Iran Red Crescent Med J 2012; 14: 164\u201370.","journal-title":"Iran Red Crescent Med J"},{"key":"BFaps201754_CR27","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/jps.24250","volume":"104","author":"H Sun","year":"2015","unstructured":"Sun H, Zhang T, Wu Z, Wu B . Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine. J Pharm Sci 2015; 104: 244\u201356.","journal-title":"J Pharm Sci"},{"key":"BFaps201754_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.antiviral.2009.03.010","volume":"83","author":"MA Quevedo","year":"2009","unstructured":"Quevedo MA . Bri\u00f1\u00f3n MC . In vitro and in vivo pharmacokinetic characterization of two novel prodrugs of zidovudine. Antiviral Res 2009; 83: 103\u201311.","journal-title":"Antiviral Res"},{"key":"BFaps201754_CR29","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1208\/s12249-008-9122-0","volume":"9","author":"S Wannachaiyasit","year":"2008","unstructured":"Wannachaiyasit S, Chanvorachote P, Nimmannit U . A novel anti-HIV dextrin-zidovudine conjugate improving the pharmacokinetics of zidovudine in rats. AAPS Pharm Sci Tech 2008; 9: 840\u201350.","journal-title":"AAPS Pharm Sci Tech"},{"key":"BFaps201754_CR30","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1124\/dmd.111.043513","volume":"40","author":"H Liu","year":"2012","unstructured":"Liu H, Liu L, Li J, Mei D, Duan R, Hu N, et al. Combined contributions of impaired hepatic cyp2c11 and intestinal bcrp activities and expressions to increased exposure of oral glibenclamide in streptozotocin-induced diabetic rats. Drug Metab Dispos 2012; 40: 1104\u201312.","journal-title":"Drug Metab Dispos"},{"key":"BFaps201754_CR31","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1124\/dmd.106.014225","volume":"35","author":"Y Mano","year":"2007","unstructured":"Mano Y, Usui T, Kamimura H . Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes. Drug Metab Dispos 2007; 35: 602\u20136.","journal-title":"Drug Metab Dispos"},{"key":"BFaps201754_CR32","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1124\/dmd.31.9.1125","volume":"31","author":"MH Court","year":"2003","unstructured":"Court MH, Krishnaswamy S, Hao Q, Duan SX, Patten CJ, Von Moltke LL, et al. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: Specificity and influence of the UGT2B7*2 polymorphism. Drug Metab Dispos 2003; 31: 1125\u201333.","journal-title":"Drug Metab Dispos"},{"key":"BFaps201754_CR33","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/jnc.12944","volume":"131","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhang M, Sun B, Li Y, Xu P, Liu C, et al. Hyperammonemia enhances the function and expression of P-glycoprotein and Mrp2 at the blood-brain barrier through NF-\u03baB. J Neurochem 2014; 131: 791\u2013802.","journal-title":"J Neurochem"},{"key":"BFaps201754_CR34","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.bcp.2007.08.021","volume":"74","author":"YC Liu","year":"2007","unstructured":"Liu YC, Liu HY, Yang HW, Wen T, Shang Y, Liu XD, et al. Impaired expression and function of breast cancer resistance protein (Bcrp) in brain cortex of streptozocin-induced diabetic rats. Biochem Pharmacol 2007; 74: 1766\u201372.","journal-title":"Biochem Pharmacol"},{"key":"BFaps201754_CR35","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/aps.2016.54","volume":"37","author":"ZY Zhong","year":"2016","unstructured":"Zhong ZY, Sun BB, Shu N, Xie QS, Tang XG, Ling ZL, et al. Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal \u03b2-glucuronidase activity. Acta Pharmacol Sin 2016; 37: 1002\u201312.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps201754_CR36","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.1208\/ps030325","volume":"3","author":"SC Sutton","year":"2001","unstructured":"Sutton SC, Rinaldi MT, Vukovinsky KE . Comparison of the gravimetric, phenol red, and 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model. AAPS PharmSci 2001; 3: E25.","journal-title":"AAPS PharmSci"},{"key":"BFaps201754_CR37","doi-asserted-by":"publisher","first-page":"e0161750","DOI":"10.1371\/journal.pone.0161750","volume":"11","author":"F Ramalhosa","year":"2016","unstructured":"Ramalhosa F, Soares-Cunha C, Seixal RM, Sousa N, Carvalho AF . The impact of prenatal exposure to dexamethasone on gastrointestinal function in rats. PLoS One 2016; 11: e0161750.","journal-title":"PLoS One"},{"key":"BFaps201754_CR38","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.taap.2007.09.007","volume":"226","author":"RL Divi","year":"2008","unstructured":"Divi RL, Doerge DR, Twaddle NC, Shockley ME, St Claire MC, et al. Metabolism and pharmacokinetics of the combination Zidovudine plus Lamivudine in the adult Erythrocebus patas monkey determined by liquid chromatography-tandem mass spectrometric analysis. Toxicol Appl Pharmacol. 2008; 226: 206\u201311.","journal-title":"Toxicol Appl Pharmacol."},{"key":"BFaps201754_CR39","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3109\/00498254.2014.891780","volume":"44","author":"H Liu","year":"2014","unstructured":"Liu H, Sun H, Lu D, Zhang Y, Zhang X, Ma Z, et al. Identification of glucuronidation and biliary excretion as the main mechanisms for gossypol clearance: in vivo and in vitro evidence. Xenobiotica 2014; 44: 696\u2013707.","journal-title":"Xenobiotica"},{"key":"BFaps201754_CR40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.5414\/CPP44240","volume":"44","author":"JF Marier","year":"2006","unstructured":"Marier JF, Manthos H, Kebir S, Ferron S, DiMarco M, Morelli G, et al. Comparative bioavailability study of zidovudine administered as two different tablet formulations in healthy adult subjects. Int J Clin Pharm Th 2006; 44: 240\u20136.","journal-title":"Int J Clin Pharm Th"},{"key":"BFaps201754_CR41","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.neuropharm.2007.07.012","volume":"53","author":"X Liu","year":"2007","unstructured":"Liu X, Yang Z, Yang J, Yang H . Increased P-glycoprotein expression and decreased phenobarbital distribution in the brain of pentyl-enetetrazole-kindled rats. Neuropharmacology 2007; 53: 657\u201363.","journal-title":"Neuropharmacology"},{"key":"BFaps201754_CR42","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0022-3565(25)20528-6","volume":"259","author":"DC Mays","year":"1991","unstructured":"Mays DC, Dixon KF, Balboa A, Pawluk LJ, Bauer MR, Nawoot S, et al. A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats. J Pharmacol Exp Ther 1991; 259: 1261\u201370.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps201754_CR43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0090-9556(25)08491-0","volume":"18","author":"P de Miranda","year":"1990","unstructured":"de Miranda P, Burnette TC, Good SS . Tissue distribution and metabolic disposition of zidovudine in rats. Drug Metab Dispos 1990; 18: 315\u201320.","journal-title":"Drug Metab Dispos"},{"key":"BFaps201754_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.brainres.2014.07.001","volume":"1578","author":"BE Faleiros","year":"2014","unstructured":"Faleiros BE, Miranda AS, Campos AC, Gomides LF, Kangussu LM, Guatimosim C, et al. Up-regulation of brain cytokines and chemokines mediates neurotoxicity in early acute liver failure by a mechanism independent of microglial activation. Brain Res 2014; 1578: 49\u201359.","journal-title":"Brain Res"},{"key":"BFaps201754_CR45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1086\/426021","volume":"40","author":"DL Wyles","year":"2005","unstructured":"Wyles DL, Gerber JG . Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction. Clin Infect Dis 2005; 40: 174\u201381.","journal-title":"Clin Infect Dis"},{"key":"BFaps201754_CR46","first-page":"551","volume":"34","author":"JY Chatton","year":"1992","unstructured":"Chatton JY, Munafo A, Chave JP, Steinh\u00e4uslin F, Roch-Ramel F, Glauser MP, et al. Trimethoprim, alone or in combination with sulphamethoxazole, decreases the renal excretion of zidovudine and its glucuronide. Br J Clin Pharmacol 1992; 34: 551\u20134.","journal-title":"Br J Clin Pharmacol"},{"key":"BFaps201754_CR47","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1128\/AAC.43.7.1708","volume":"43","author":"LH Wang","year":"1999","unstructured":"Wang LH, Chittick GE, McDowell JA . Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection. Antimicrob Agents Chemother 1999; 43: 1708\u201315.","journal-title":"Antimicrob Agents Chemother"},{"key":"BFaps201754_CR48","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1208\/s12248-015-9792-y","volume":"17","author":"GD Anderson","year":"2015","unstructured":"Anderson GD, Peterson TC, Vonder Haar C, Farin FM, Bammler TK, MacDonald JW, et al. Effect of traumatic brain injury, erythropoietin, and anakinra on hepatic metabolizing enzymes and transporters in an experimental rat model. AAPS J 2015; 17: 1255\u201367.","journal-title":"AAPS J"},{"key":"BFaps201754_CR49","doi-asserted-by":"publisher","first-page":"e0127524","DOI":"10.1371\/journal.pone.0127524","volume":"10","author":"L Lu","year":"2015","unstructured":"Lu L, Zhou J, Shi J, Peng XJ, Qi XX, Wang Y, et al. Drug-metabolizing activity, protein and gene expression of UDP-glucuronosyltransferases are significantly altered in hepatocellular carcinoma patients. PLoS One 2015; 10: e0127524.","journal-title":"PLoS One"},{"key":"BFaps201754_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1124\/dmd.30.2.129","volume":"30","author":"M Congiu","year":"2002","unstructured":"Congiu M, Mashford ML, Slavin JL, Desmond PV . UDP glucuronosyltransferase mRNA levels in human liver disease. Drug Metab Dispos 2002; 30: 129\u201334.","journal-title":"Drug Metab Dispos"},{"key":"BFaps201754_CR51","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1021\/tx300310k","volume":"25","author":"L Zhu","year":"2012","unstructured":"Zhu L, Ge G, Liu Y, Guo Z, Peng C, Zhang F, et al. Characterization of UDP-glucuronosyltransferases involved in glucuronidation of diethylstilbestrol in human liver and intestine. Chem Res Toxicol 2012; 25: 2663\u20139.","journal-title":"Chem Res Toxicol"},{"key":"BFaps201754_CR52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1124\/dmd.107.018747","volume":"36","author":"ET Morgan","year":"2008","unstructured":"Morgan ET, Goralski KB, Piquette-Miller M, Renton KW, Robertson GR, Chaluvadi MR, et al. Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos 2008; 36: 205\u201316.","journal-title":"Drug Metab Dispos"},{"key":"BFaps201754_CR53","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/clpt.2008.302","volume":"85","author":"ET Morgan","year":"2009","unstructured":"Morgan ET . Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics. Clin Pharmacol Ther 2009; 85: 434\u20138.","journal-title":"Clin Pharmacol Ther"},{"key":"BFaps201754_CR54","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1124\/dmd.105.007435","volume":"34","author":"TA Richardson","year":"2006","unstructured":"Richardson TA, Sherman M, Kalman D, Morgan ET . Expression of UDP-glucuronosyltransferase isoform mRNAs during inflammation and infection in mouse liver and kidney. Drug Metab Dispos 2006; 34: 351\u20133.","journal-title":"Drug Metab Dispos"},{"key":"BFaps201754_CR55","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1124\/dmd.113.054957","volume":"42","author":"SM Mimche","year":"2014","unstructured":"Mimche SM, Nyagode BA, Merrell MD, Lee CM, Prasanphanich NS, Cummings RD, et al. Hepatic cytochrome P450s, phase II enzymes and nuclear receptors are downregulated in a Th2 environment during Schistosoma mansoni infection. Drug Metab Dispos 2014; 42: 134\u201340.","journal-title":"Drug Metab Dispos"},{"key":"BFaps201754_CR56","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.toxlet.2012.07.014","volume":"213","author":"D Gradinaru","year":"2012","unstructured":"Gradinaru D, Minn AL, Artur Y, Minn A, Heydel JM . Effect of oxidative stress on UDP-glucuronosyltransferases in rat astrocytes. Toxicol Lett 2012; 213: 316\u201324.","journal-title":"Toxicol Lett"},{"key":"BFaps201754_CR57","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/bdd.1993","volume":"37","author":"Z Neumanova","year":"2016","unstructured":"Neumanova Z, Cerveny L, Ceckova M, Staud F . Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine. Biopharm Drug Dispos 2016; 37: 28\u201338.","journal-title":"Biopharm Drug Dispos"},{"key":"BFaps201754_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.taap.2016.06.030","volume":"306","author":"Y Jia","year":"2016","unstructured":"Jia Y, Liu Z, Wang C, Meng Q, Huo X, Liu Q, et al. P-gp, MRP2 and OAT1\/OAT3 mediate the drug-drug interaction between resveratrol and methotrexate. Toxicol Appl Pharmacol 2016; 306: 27\u201335.","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFaps201754_CR59","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ejps.2013.08.010","volume":"50","author":"X Huo","year":"2013","unstructured":"Huo X, Liu Q, Wang C, Meng Q, Sun H, Peng J, et al. Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin. Eur J Pharm Sci 2013; 50: 420\u20138.","journal-title":"Eur J Pharm Sci"},{"key":"BFaps201754_CR60","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejps.2011.04.007","volume":"43","author":"MA Quevedo","year":"2011","unstructured":"Quevedo MA, Nieto LE, Brinon MC . P-glycoprotein limits the absorption of the anti-HIV drug zidovudine through rat intestinal segments. Eur J Pharm Sci 2011; 43: 151\u20139.","journal-title":"Eur J Pharm Sci"},{"key":"BFaps201754_CR61","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1089\/aid.1996.12.1457","volume":"12","author":"A Andreana","year":"1996","unstructured":"Andreana A, Aggarwal S, Gollapudi S, Wien D, Tsuruo T, Gupta S . Abnormal expression of a 170-kilodalton P-glycoprotein encoded by MDR1 gene, a metabolically active efflux pump, in CD4+ and CD8+ T cells from patients with human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1996; 12: 1457\u201362.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"BFaps201754_CR62","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.pharmthera.2012.07.010","volume":"136","author":"G Burckhardt","year":"2012","unstructured":"Burckhardt G . Drug transport by organic anion transporters (OATs). Pharmacol Ther 2012; 136: 106\u201330.","journal-title":"Pharmacol Ther"},{"key":"BFaps201754_CR63","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0022-3565(24)29490-8","volume":"298","author":"N Morita","year":"2001","unstructured":"Morita N, Kusuhara H, Sekine T, Endou H, Sugiyama Y . Functional characterization of rat organic anion transporter 2 in LLC-PK1 cells. J Pharmacol Exp Ther 2001; 298: 1179\u201384.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps201754_CR64","doi-asserted-by":"publisher","first-page":"8654","DOI":"10.1074\/jbc.M708615200","volume":"283","author":"DM Truong","year":"2008","unstructured":"Truong DM, Kaler G, Khandelwal A, Swaan PW, Nigam SK . Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences instructural determinants of antiviral discrimination. J Biol Chem 2008; 283: 8654\u201363.","journal-title":"J Biol Chem"},{"key":"BFaps201754_CR65","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000356643","volume":"86","author":"Y Yasui","year":"2014","unstructured":"Yasui Y, Kudo A, Kurosaki M, Matsuda S, Muraoka M, Tamaki N, et al. Reduced organic anion transporter expression is a risk factor for hepatocellular carcinoma in chronic hepatitis C patients: a propensity score matching study. Oncology 2014; 86: 53\u201362.","journal-title":"Oncology"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps201754.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201754","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/aps.2017.54","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/aps201754.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T20:16:18Z","timestamp":1750796178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps201754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,3]]},"references-count":65,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["BFaps201754"],"URL":"https:\/\/doi.org\/10.1038\/aps.2017.54","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,3]]},"assertion":[{"value":"10 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}